Current Report Filing (8-k)
January 23 2019 - 3:57PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 23, 2019
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
New York
|
|
0-16093
|
|
16-0977505
|
(State or other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
525 French Road
|
|
|
Utica, New York
|
|
13502
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code: (315)
797-8375
(Former name or former address if changed since last report.)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On January 23, 2019, CONMED Corporation issued a press release to announce that it intends to offer $275 million aggregate principal
amount of convertible senior notes due 2024 in a private placement. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
CONMED CORPORATION
|
(Registrant)
|
|
|
By:
|
|
/s/ Todd W. Garner
|
Name:
|
|
Todd W. Garner
|
Title:
|
|
Executive Vice President
and Chief Financial
Officer
|
Date: January 23, 2019
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
CONMED (NASDAQ:CNMD)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about CONMED Corporation (NASDAQ): 0 recent articles
More Conmed Corp News Articles